Sotra Pharma Limited - Period Ending 2015-12-31

Sotra Pharma Limited 05230171 false true 2015-01-01 2015-12-31 2015-12-31 05230171 2015-01-01 2015-12-31 05230171 2015-12-31 05230171 uk-bus:OrdinaryShareClass1 2015-12-31 05230171 uk-bus:Director2 2015-01-01 2015-12-31 05230171 uk-bus:OrdinaryShareClass1 2015-01-01 2015-12-31 05230171 uk-bus:EntityAccountantsOrAuditors 2015-01-01 2015-12-31 05230171 2014-12-31 05230171 2014-12-31 05230171 uk-bus:OrdinaryShareClass1 2014-12-31 iso4217:GBP xbrli:shares

Registration number: 05230171

Sotra Pharma Limited
 

 
Abbreviated Accounts
 

 
for the Year Ended 31 December 2015
 

Brooks Green
 
Accountants

 
Abbey House

 
342 Regents Park Road

 
London

 
N3 2LJ

 

Sotra Pharma Limited
Contents

Accountants' Report

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

3

 

The following reproduces the text of the accountants' report in respect of the company's annual financial statements, from which the abbreviated accounts (set out on pages 2 to 3) have been prepared.

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Sotra Pharma Limited
for the Year Ended 31 December 2015

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Sotra Pharma Limited for the year ended 31 December 2015 set out on pages from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at icaew.com/membershandbook.

This report is made solely to the Board of Directors of Sotra Pharma Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Sotra Pharma Limited and state those matters that we have agreed to state to them, as a body, in this report in accordance with AAF 2/10 as detailed at icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Sotra Pharma Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Sotra Pharma Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Sotra Pharma Limited. You consider that Sotra Pharma Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Sotra Pharma Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Brooks Green
Accountants
Abbey House
342 Regents Park Road
London
N3 2LJ

22 March 2016

 

Sotra Pharma Limited
(Registration number: 05230171)
Abbreviated Balance Sheet at 31 December 2015

   

Note

   

2015
£

   

2014
£

 

Current assets

 

             

Debtors

 

   

-

   

6

 

Cash at bank and in hand

 

   

3,193

   

6,895

 
   

   

3,193

   

6,901

 

Creditors: Amounts falling due within one year

 

   

(44,792)

   

(52,967)

 

Net liabilities

 

   

(41,599)

   

(46,066)

 

Capital and reserves

 

             

Called up share capital

 

2

   

50,000

   

50,000

 

Profit and loss account

 

   

(91,599)

   

(96,066)

 

Shareholders' deficit

 

   

(41,599)

   

(46,066)

 

For the year ending 31 December 2015 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime .

Approved by the Board on 18 March 2016 and signed on its behalf by:

......................................................
Mr M Wijsmuller
Director

 

The notes on page 3 form an integral part of these financial statements.
Page 2

 

Sotra Pharma Limited
Notes to the Abbreviated Accounts for the Year Ended 31 December 2015
......... continued

1

Accounting policies

Basis of preparation

The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (Effective January 2015).

Turnover

Turnover represents amounts chargeable in respect of the sale of goods and services to customers.

Foreign currency

Transactions in foreign currencies are recorded at the exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the closing rates at the balance sheet date. All exchange differences are included in the profit and loss account.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability in the balance sheet. The corresponding dividends relating to the liability component are charged as interest expense in the profit and loss account.

2

Share capital

Allotted, called up and fully paid shares

 

2015

2014

   

No.

   

£

   

No.

   

£

 

Ordinary of £1 each

 

50,000

   

50,000

   

50,000

   

50,000

 
                         

3

Control

The company is controlled by The Odal Trust which is registered in Guernsey, Channel Islands .